Smartphone app to aid brain injury sufferers
November 21, 2013Medical Communications brain, brain in hand, digital, glenside, smartphone, wells
Neurological rehabilitation firm Glenside are running a large-scale pilot which uses smartphone technology to improve the lives of people with …
NHS responds to Mid Staffs
November 21, 2013Sales and Marketing Francis, Mid Staffs, NHS, UK
The government has accepted 281 out of the 290 recommendations contained in the Francis report – the damning document published …
Novasep appoints president of Industrial Biotech business
November 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novasep
French processing equipment supplier Novasep has appointed Nadege Laborde as the new president of its Industrial Biotech business unit. It …
Global prescriptions cost to hit $1 trillion
November 20, 2013Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions
The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …
EMA looks to sharpen HTA data output
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency
The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …
Healthcare UK appoints medical director
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, healthcare uk
Professor Rory Shaw has been hired as the medical director of Healthcare UK to lead the newly-established NHS International Development …
AstraZeneca sells arthritis drug for $35 million
November 20, 2013Sales and Marketing AstraZeneca, RA, arthritis, horizon, vimovo
AstraZeneca has sold rights to its arthritis treatment Vimovo to speciality pharma firm Horizon Pharma for $35 million. AZ retains …
Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers
November 20, 2013Manufacturing and Production auto injector, autoinjector, autoinjector innovation, shl autoinjector
SHL’s recent article “Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers” was featured in …
SHL introduces new mobile website
November 20, 2013Manufacturing and Production shl group, shl mobile, shl social media
SHL recently introduced a mobile website which allows mobile device users to view the company’s corporate website in a more …
Pfizer launches another ‘medicine optimisation’ campaign
November 19, 2013Medical Communications Pfizer, RPS, npa, treatments
Patients would be more likely to follow prescriptions if they had better knowledge about the drugs they were taking according …
Charge more for prescriptions in England, say Reform
November 19, 2013Sales and Marketing GP, NHS, UK, doctors, prescriptions, reform
Increase prescriptions to £10 and charge the same amount to see a GP if you want to help the NHS …
Merck’s melanoma vaccine impresses
November 19, 2013Research and Development, Sales and Marketing MK-3475, Merck, Roche, melanoma
Merck has posted impressive results for its new melanoma vaccine MK-3475 as it looks to vie for a place in …
Immunocore promotes non-executive to chairman
November 19, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunocore, knowles
Oxford-based biotech firm Immunocore has appointed Dr Jonathan Knowles as the new executive chairman of its Board of directors. Knowles …
Sanofi discards blood cancer drug in late-stage
November 19, 2013Research and Development, Sales and Marketing Sanofi, Wernicke's encephalopathy, fedratinib
Sanofi has scrapped its regulatory filing plans and late-stage trials for rare bone marrow cancer treatment fedratinib. The reason given …
Scientists map cancer ‘family tree’
November 18, 2013Research and Development, Sales and Marketing Cancer, DNA, ICR, family tree
A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …
Bayer cancer drug gets EU approval
November 18, 2013Sales and Marketing Bayer, CHMP, EU, Xtandi, Zytiga, xofigo
Bayer’s prostate cancer treatment Xofigo has been shown the green light by the European Commission. Xofigo (radium Ra 223 dichloride) …
Merck and J&J invest in Chinese manufacturing
November 18, 2013Manufacturing and Production J&J, JJ, Merck, manufacturing
Merck KGaA and Johnson & Johnson have both announced new manufacturing projects in China, suggesting investigations into corruption by the …
Lilly plans $700m insulin plant expansion programme
November 18, 2013Manufacturing and Production Taylor, lilly, manufacturing
Eli Lilly has said it will invest more than $700 million to expand its production capacity for insulin products in …
UK agency urged to ‘press’ EMA on speed reviews
November 18, 2013Research and Development, Sales and Marketing BIA, EMA, EU, MHRA
A new advisory group for the UK drugs regulator wants Europe to follow the lead of the US by introducing …
NICE tells pharma: don’t blame us for rejections
November 18, 2013Sales and Marketing Dillon, NHS, NICE, VBP
The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
